Nexalin Technology (NXL) FCF Margin (2021 - 2026)
Nexalin Technology (NXL) recorded quarterly FCF Margin of 11787.72% in Q1 2026, down 1664.99% quarter-over-quarter from 667.86% in Q4 2025, and down 831042.0% on a YoY basis from N/an in Q1 2025.
Nexalin Technology (NXL) FCF Margin (2021 - 2026) Analysis & Trends
Nexalin Technology's FCF Margin history runs 6 years deep, the most recent figure standing at 11787.72% for Q1 2026.
- In Q1 2026, FCF Margin fell 831042.0% year-over-year to 11787.72%; the TTM figure through Mar 2026 stood at 1920.92% (up 159437.0% YoY), while the FY2025 annual figure was 1643.53%, up 69429.0% from the prior year.
- FCF Margin was 11787.72% for Q1 2026 at Nexalin Technology, down from 667.86% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 39.17% in Q2 2022 to a low of 11787.72% in Q1 2026.
- Historically, FCF Margin has averaged 3196.93% across 5 years, with a median of 2359.09% in 2022.
- The sharpest annual moves came in 2025 and 2026: FCF Margin surged 350623 bps in 2025, then sank 831042 bps in 2026.
- A 5-year view of FCF Margin shows it stood at 2359.09% in 2022, then plunged by 107 bps to 4889.12% in 2023, then climbed by 15 bps to 4174.09% in 2024, then soared by 84 bps to 667.86% in 2025, then sank by 1665 bps to 11787.72% in 2026.
- The last three FCF Margin figures came in at 11787.72% (Q1 2026), 667.86% (Q4 2025), and 8079.0% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 15.44% |
| 10 | Nexalin Technology | 7.82 Mn | 5.11 Mn | 13,133.00 | -11,787.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11,787.72% |
| Dec 31, 2025 | -667.86% |
| Sep 30, 2025 | -8,079.00% |
| Jun 30, 2025 | -1,299.32% |
| Mar 31, 2025 | -3,477.30% |
| Dec 31, 2024 | -4,174.09% |
| Sep 30, 2024 | -2,220.89% |
| Jun 30, 2024 | -4,643.87% |
| Mar 31, 2024 | -970.23% |
| Dec 31, 2023 | -4,889.12% |
| Sep 30, 2023 | -2,907.54% |
| Jun 30, 2023 | -2,294.91% |
| Mar 31, 2023 | -4,301.86% |
| Dec 31, 2022 | -2,359.09% |
| Sep 30, 2022 | -173.05% |
| Jun 30, 2022 | -39.17% |
| Mar 31, 2022 | -62.87% |
| Dec 31, 2021 | -1,704.62% |